Transplant immunologyHumansLung TransplantationRetrospective StudiesMaleFemale
Conversion to belatacept-based immunosuppression as a calcineurin sparing regimen in lung transplant: A multi-institutional retrospective study.
Moustafa Younis, Cecelia M Miller, Christopher I Mederos, Ariana Ishaq, Pooja Kumar, Biplab Saha, Cynthia Gries, Victoria Reams, Vaidehi Kaza, Srinivas Bollineni, Fernando Torres, Mohammad A Aladaileh, Mindaugas Rackauskas, Irina Timofte, Amir Emtiazjoo
Published: 202610.1016/j.trim.2025.102330
Abstract
BACKGROUND: Calcineurin inhibitor (CNI) related kidney dysfunction is common and associated with worse outcomes after lung transplantation (LTx). To mitigate that risk, belatacept use in a CNI-sparing regimen is an alternative in LTx. We aim to descr…
Preview only. Read the full abstract at the source